Stay updated on TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial
Sign up to get notified when there's something new on the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page.

Latest updates to the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check30 days agoChange DetectedUpdates to versioning (v3.0.2 to v3.1.0) with removal of multiple drug-safety topics; core content likely re-scoped and some safety topics removed.SummaryDifference0.4%

- Check44 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the Back to Top element has been removed.SummaryDifference0.2%

- Check51 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.2%

- Check58 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to drug safety and information, specifically regarding Fremanezumab and counterfeit drugs. Several previous sections, including specific location details and various medical resources, have been removed.SummaryDifference2%

- Check73 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page.